company
as of 2026-07-01Tanabe Pharma Corporation
at a glance
7 trials sponsored · 7 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
7 assets
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Cariprazine (Vraylar)
drugsmall molecule
Risperidone
drugsmall molecule
MP-214
drugsmall molecule
MP-214 3mg
drugsmall molecule
MP-214 6mg
drugsmall molecule
MP-214 9mg
drugsmall molecule
Tryptophan
drugsmall molecule